BioMarin Pharmaceutical (BMRN): Q3 EPS of $0.06 may not be comparable to consensus of $0.01....

|About: BioMarin Pharmaceutical Inc. (BMRN)|By:, SA News Editor
BioMarin Pharmaceutical (BMRN): Q3 EPS of $0.06 may not be comparable to consensus of $0.01. Revenue of $98M (+21%) in-line. Shares -0.3% AH. (PR)